SULCRATE SUSPENSION PLUS
Google image searchProduct monograph
Active ingredient
sucralfate, 1 G/5 ML
DIN: 02103567
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: APTALIS PHARMA CANADA ULC
Date: 18-FEB-2013
ATC:
- A02 — DRUGS FOR ACID RELATED DISORDERS (ATC, ATC/DDD, )
- A02B — DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) (ATC, ATC/DDD)
- A02BX — Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) (ATC, ATC/DDD)
- A02BX02 — SUCRALFATE (ATC/DDD)
Reference brand drug: Sulcrate
Pharmaceutical standard: USP
